Results 31 to 40 of about 431,499 (141)

Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.

open access: yes, 2012
BACKGROUND: Treatment options for drug-resistant tuberculosis (DR-TB) are limited. Linezolid has been successfully used to treat DR-TB in adults, but there are few case reports of its use in children for TB.
Rose, PC   +4 more
core   +1 more source

Treatment of tuberculosis in a region with high drug resistance: Outcomes, drug resistance amplification and re-infection [PDF]

open access: yes, 2011
Introduction: Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especially in Eastern European countries. Methods: We combined drug susceptibility results and molecular strain typing data with treatment outcome ...
Rüsch-Gerdes Sabine   +91 more
core   +1 more source

Extensively drug-resistant (XDR) Neisseria gonorrhoeae cured with ceftriaxone 2 g intravenous monotherapy in Croatia, March 2026

open access: yesEurosurveillance
In early 2026 in Croatia, a male heterosexual patient of Croatian origin was diagnosed with extensively drug-resistant (XDR) gonorrhoea after unprotected vaginal intercourse with a Croatian female. The Neisseria gonorrhoeae HR027 isolate (genomic lineage 
Magnus Unemo
doaj   +1 more source

Emergence of Extensively Drug Resistant (XDR) Strains of Mycobacterium Tuberculosis in TB Patients in Kerala, India [PDF]

open access: yes, 2017
We report the detection of extensively drug resistant strains of Mycobacterium tuberculosis in Kerala, India. Earlier we had reported that 22 of 206 local isolates were multidrug resistant.
Leny Jose Biljo V Joseph
core   +2 more sources

Incidence and geographic distribution of extensively drug-resistant tuberculosis in KwaZulu-Natal Province, South Africa [PDF]

open access: yes, 2015
South Africa is experiencing a widespread drug-resistant tuberculosis epidemic, although data are limited regarding the current situation. This study finds that the extensively drugresistant tuberculosis (XDR-TB) incidence in KwaZulu-Natal increased to
Lim, Jennifer R.   +21 more
core   +1 more source

The The danger is not over yet: Continued outbreak of extensively drug-resistant (XDR) Salmonella has spread across Pakistan

open access: yesJournal of Microbiological Sciences
The emergence of extensively drug-resistant (XDR) Salmonella has raised concerns about the effectiveness of third-generation cephalosporins for empiric treatment.
Rao Muhammad Abid Khan   +7 more
doaj   +1 more source

Drug resistance beyond extensively drugresistant tuberculosis: Individual patient data meta-analysis

open access: yes, 2013
The broadest pattern of tuberculosis (TB) drug resistance for which a consensus definition exists is extensively drug-resistant (XDR)-TB. It is not known if additional drug resistance portends worsened patient outcomes.
Lancaster, J.   +73 more
core   +1 more source

Characterization of the Diversity in Host Range of an Extensively Drug-Resistant (XDR) Type IV Secretion System-Encoding Plasmid in Acinetobacter

open access: yesPathogens
The World Health Organization (WHO) cites antimicrobial resistance as among the greatest threats to human health. The multidrug-resistant pathogen Acinetobacter baumannii, recognized as a priority pathogen for healthcare and research, is responsible for ...
Kailey Martz   +4 more
doaj   +1 more source

Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country

open access: yes, 2015
Extensively drug-resistant tuberculosis (XDR-TB) is a serious worldwide problem. The REBA MTB-XDR (REBA-XDR) was recently developed in Korea to detect resistance to ofloxacin, kanamycin, and streptomycin.
이영석
core   +1 more source

Pattern for pre-XDR-TB and XDR-TB cases.

open access: yes
This line chart shows the pattern of pre-XDR-TB and XDR-TB across the provinces of Nepal, highlighting the provinces with the highest and lowest prevalence rates of pre-XDR-TB and XDR-TB.
Shiba Kumar Rai (16764697)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy